A carregar...
Rapidly fatal advanced EGFR-mutated lung cancers and the need for rapid tumor genotyping in clinical practice
Use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is associated with dramatic, durable, and tolerable responses and side effect profiles when applied for palliation of advanced EGFR-mutated non-small-cell lung cancers (NSCLCs). Expert guidelines recommend that EGFR mut...
Na minha lista:
| Publicado no: | Cancer Treat Commun |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5241076/ https://ncbi.nlm.nih.gov/pubmed/28111612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctarc.2016.07.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|